Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Mahvash is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Armeen Mahvash is a radiologist in Houston, TX and is affiliated with University of Texas M.D. Anderson Cancer Center. He received his medical degree from Baylor College of Medicine and has been in practice 18 years. He specializes in vascular & interventional radiology.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Vascular and Interventional Radiology, 2005 - 2006- University of Texas Health Science Center at HoustonResidency, Radiology-Diagnostic, 2000 - 2004
John Peter Smith Hospital (Tarrant County Hospital District)Internship, Transitional Year, 1999 - 2000
Baylor College of MedicineClass of 1999
Certifications & Licensure
TX State Medical License 2004 - 2026
American Board of Radiology Interventional Radiology and Diagnostic Radiology
Clinical Trials
- Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma Start of enrollment: 2010 Aug 04
- Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer Start of enrollment: 2012 Jan 01
- Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer Start of enrollment: 2017 Jan 09
- Join now to see all
Publications & Presentations
PubMed
- Outcomes of transjugular intrahepatic portosystemic shunt creation for the management of portal hypertension complications in cancer patients.Mohammad Mahdi Khavandi, Nariman Nezami, Steven Huang, Alda L Tam, Mohamed E Abdelsalam
Abdominal Radiology. 2025-05-28 - The relationship between yttrium-90 glass microspheres specific activity, particle density and treatment outcomes in HCC and mCRC.Marnix G E H Lam, Etienne Garin, Kirk D Fowers, Armeen Mahvash, Siddharth A Padia
European Journal of Nuclear Medicine and Molecular Imaging. 2025-05-22 - Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal.Van K Morris, Suyu Liu, Kangyu Lin, Haifeng Zhu, Seema Prasad
Clinical Cancer Research. 2025-05-01
Press Mentions
FDA Approves Expanded Use of Radioembolization Therapy for Liver CancerJuly 9th, 2025- FDA Approves Radioembolization Therapy for Liver CancerJuly 8th, 2025
- Sirtex Medical's SIR-Spheres® Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular CarcinomaJuly 7th, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
